These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23530949)

  • 1. Overcoming resistance to β-lactam antibiotics.
    Worthington RJ; Melander C
    J Org Chem; 2013 May; 78(9):4207-13. PubMed ID: 23530949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming β-lactam resistance in Gram-negative pathogens.
    Bush K
    Future Med Chem; 2016 Jun; 8(9):921-4. PubMed ID: 27228233
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel beta-lactam antibiotics and inhibitor combinations.
    Bassetti M; Righi E; Viscoli C
    Expert Opin Investig Drugs; 2008 Mar; 17(3):285-96. PubMed ID: 18321228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming β-Lactam resistance in Pseudomonas aeruginosa using non-canonical tobramycin-based antibiotic adjuvants.
    Idowu T; Ammeter D; Brizuela M; Jackson G; Alam S; Schweizer F
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127575. PubMed ID: 32980511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of two-component regulatory system in β-lactam antibiotics resistance.
    Lingzhi L; Haojie G; Dan G; Hongmei M; Yang L; Mengdie J; Chengkun Z; Xiaohui Z
    Microbiol Res; 2018 Oct; 215():126-129. PubMed ID: 30172298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
    Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
    Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?
    Devi P; Rutledge PJ
    Chembiochem; 2017 Feb; 18(4):338-351. PubMed ID: 27992105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muropeptides in Pseudomonas aeruginosa and their Role as Elicitors of β-Lactam-Antibiotic Resistance.
    Lee M; Dhar S; De Benedetti S; Hesek D; Boggess B; Blázquez B; Mathee K; Mobashery S
    Angew Chem Int Ed Engl; 2016 Jun; 55(24):6882-6. PubMed ID: 27111486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.
    Tomoshige S; Dik DA; Akabane-Nakata M; Madukoma CS; Fisher JF; Shrout JD; Mobashery S
    ACS Infect Dis; 2018 Jun; 4(6):860-867. PubMed ID: 29716193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams.
    King DT; Sobhanifar S; Strynadka NC
    Protein Sci; 2016 Apr; 25(4):787-803. PubMed ID: 26813250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Lactamases: A Focus on Current Challenges.
    Bonomo RA
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of β-Lactamases. New Life of β-Lactam Antibiotics.
    Egorov AM; Ulyashova MM; Rubtsova MY
    Biochemistry (Mosc); 2020 Nov; 85(11):1292-1309. PubMed ID: 33280574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and studies of new forms of N-sulfonyloxy β-lactams as potential antibacterial agents and β-lactamase inhibitors.
    Carosso S; Miller MJ
    Bioorg Med Chem; 2015 Sep; 23(18):6138-47. PubMed ID: 26321604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.
    Bebrone C; Lassaux P; Vercheval L; Sohier JS; Jehaes A; Sauvage E; Galleni M
    Drugs; 2010 Apr; 70(6):651-79. PubMed ID: 20394454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
    Buynak JD
    Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2018-2019 patent review of metallo beta-lactamase inhibitors.
    Reddy N; Shungube M; Arvidsson PI; Baijnath S; Kruger HG; Govender T; Naicker T
    Expert Opin Ther Pat; 2020 Jul; 30(7):541-555. PubMed ID: 32393078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
    Buynak JD
    Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors.
    Sandanayaka VP; Prashad AS
    Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.